1-4 of 4
Jennifer L Shah
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Single-Agent Rituximab and Ultra-Low-Dose Adaptive Radiotherapy for the Treatment of Indolent Non-Hodgkin Lymphoma

Meredith Jackson, Sean All, Samantha Brocklehurst, Neil B Desai, Jennifer L Shah, Syed M Rizvi, Farrukh T. Awan, Praveen Ramakrishnan Geethakumari, Kiran A Kumar
Journal: Blood
Blood (2021) 138 (Supplement 1): 4510.
https://doi.org/10.1182/blood-2021-154354
Published: 2021
Journal Articles

Hypofractionated Low-Dose Total Skin Electron Beam Therapy for Primary Cutaneous T-Cell Lymphoma: Analysis of Efficacy and Toxicity

Sofia F Yi, Akshat M Patel, Syed M Rizvi, Praveen Ramakrishnan Geethakumari, Jennifer L Shah, Neil B Desai, Heather W Goff, Kiran A Kumar
Journal: Blood
Blood (2021) 138 (Supplement 1): 1372.
https://doi.org/10.1182/blood-2021-153958
Published: 2021
Journal Articles

CAR T-Cell Therapy in Relapsed/Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL): A 'Real-World' Analysis of Patterns of Failure and Role of Bridging Therapy

Revathi Ravella, BA, Elizabeth Ren Zhang-Velten, MD PhD, Farrukh T Awan, MD, Syed M Rizvi, MD, Jennifer L Shah, MD, Neil B Desai, MD MHS, Praveen Ramakrishnan Geethakumari, MD MS, Kiran A Kumar, MD MBA
Journal: Blood
Blood (2020) 136 (Supplement 1): 22–23.
https://doi.org/10.1182/blood-2020-141445
Published: 2020
Journal Articles

Combined Modality Low-Dose Radiation Therapy (2 Gy x 2) and Single-Agent Rituximab Immunotherapy in the Treatment of Indolent Non-Hodgkin Lymphoma

Samantha Brocklehurst, Neil Desai, MD MHS, Jennifer L Shah, MD, Syed Rizvi, MD, Praveen Ramakrishnan Geethakumari, MD, Kiran A Kumar, MD MBA
Journal: Blood
Blood (2019) 134 (Supplement_1): 5262.
https://doi.org/10.1182/blood-2019-131246
Published: 2019